This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Nature Reviews Cardiology, Published online: 26 June 2024; doi:10.1038/s41569-024-01046-6 In this Review, Khan and colleagues explore the evolving global epidemiology of heartfailure (HF), focusing on changes in incidence and prevalence across the spectrum of left ventricular ejection fraction.
a biomarker-guided predictive care company, has presented data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heartfailure monitoring detected twice as many heartfailure events as compared to the weight-based standard of care. Bodyport Inc., Image courtesy: Bodyport Inc.
We over-admit low risk acute heartfailure patients and under-admit high risk heartfailure patients. The post Ep 197 Acute HeartFailure Risk Stratification and Disposition appeared first on Emergency Medicine Cases.
Statement Highlights: Previous studies have found that 14-81% of patients with heartfailure experience some degree of cognitive impairment affecting language, memory or executive function. Evidence also indicates that people with atrial fibrillation.
A new small study has revealed the impact of obesity on muscle structure in patients having a form of heartfailure called heartfailure with a preserved ejection fraction (HFpEF).
An analysis of blood samples from thousands of study participants, led by researchers at UT Southwestern Medical Center, revealed 18 proteins associated with both heartfailure and frailty, conditions that commonly develop in late life.
The Resynchronization–Defibrillation for Ambulatory HeartFailure Trial (RAFT; NCT00251251 ) demonstrated a greater 5-year mortality benefit for patients receiving cardiac-resynchronization therapy (CRT) compared to those receiving implantable cardioverter–defibrillators (ICDs). The median follow-up duration for these patients was 7.7
have the lowest death rate for heartfailure patients in the country, according to CMS data. Chicago-based Northwestern Memorial Hospital and VA Boston Healthcare System-Jamaica Plain (Mass.)
Despite proven benefits in reducing morbidity and mortality, many heartfailure (HF) patients do not receive optimal guideline-directed medical therapy (GDMT). ESC HeartFailure 2024; 11 : 560–569. The post Digital Consults to Enhance HeartFailure Treatment: The ADMINISTER Trial appeared first on Cardiology Update.
Research Highlights: In mice with heartfailure with preserved ejection fraction (HFpEF), increasing ketone supply to the heart allowed their hearts to utilize more ketones and produce more energy. Researchers hope this study may help to improve our.
The FDA has approved an artificial intelligence algorithm for Eko Health's digital stethoscope that can detect low ejection fraction, a key indicator of heartfailure.
Getty Images milla1cf Tue, 04/30/2024 - 12:56 April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center ( VUMC ) and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heartfailure , a leading cause of hospitalization and death. hospitals from emergency rooms.
This prespecified analysis of the Finerenone Trial to Investigate the Efficacy and Safety Superior to Placebo in Patients With HeartFailure (FINEARTS-HF) randomized clinical trial investigates the long-term effects of treatment with the nonsteroidal mineralocorticoid receptor antagonist, finerenone, in patients with heartfailure with mildly reduced (..)
(MedPage Today) -- Use of electronic nicotine products was associated with incident heartfailure, a prospective study found. People who self-reported ever having used electronic cigarettes (e-cigarettes) were 19% more likely to develop heart.
milla1cf Mon, 02/26/2024 - 12:40 February 26, 2024 — More than 6 million Americans live with heartfailure , and about half have an enlarged left ventricle, which causes stress on the heart and less blood pumped with each heartbeat. Patients may experience trouble breathing and fatigue, and at times require hospitalization.
(‘Reprieve’), a development stage company focused on pioneering an intelligent approach to acute decompensated heartfailure (ADHF) treatment, today highlighted the publication of TREAT-AHF study results in JACC: HeartFailure. Heartfailure (HF) is a leading cause of hospitalization in the United States.
CMS has reviewed the CardiAMP HeartFailure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. The CardiAMP HeartFailure II Trial is FDA approved to enroll up to 250 patients at up to 40 clinical centers. said Peter Altman , PhD.,
recently announced that Digitiva, a non-invasive digital health solution for heartfailure management, has been listed with the U.S. a smartphone app designed for heartfailure patients and built on the Welldoc, Inc. a smartphone app designed for heartfailure patients and built on the Welldoc, Inc.
Heartfailure (HF) is increasing at an alarming rate, primary due to the rising in aging, obesity and diabetes. Notably, individuals with type 1 diabetes (T1D) face a significantly elevated risk of HF, leading.
healthcare providers can now detect Low EF, a key heartfailure indicator, in 15 seconds using an Eko stethoscope during a routine physical examination. As a result, many heartfailure cases go undiagnosed until symptoms force a specialist or emergency hospital visit, leading to worse patient outcomes and exacerbated healthcare costs.2
Matthew Segar co-authored a study in JACC HeartFailure led by his research and residency mentor, University of Texas Southwestern Medical Center's Dr. Ambarish Pandey , that utilized a machine learning-based-approach to identify, understand, and predict diuretic responsiveness in patients with acute decompensated heartfailure (ADHF).
This study by Fujita Health University researchers revealed that kidney function, considered in terms of estimated glomerular filtration rate (eGFR), can be used as a predictor for SCD in patients with congestive heartfailure. During the follow-up period, 198 of these patients suffered from SCD.
A research team from the Nagoya University Graduate School of Medicine has discovered a promising way to slow the progression of heartfailure in mice. They fed mice a diet rich in the soybean protein, β-conglycinin (β-CG), which can support heart health by influencing gut bacteria.
However, information on its efficacy and safety in patients with heartfailure remains limited. Case presentation A 43-year-old man with a body mass index of 41 kg/m 2 was admitted to our hospital for acute heartfailure due to dilated cardiomyopathy. No adverse events were observed during B-SES.
Research Highlights: Pharmacists in the Veterans Health Administration System who received feedback on their patients' heartfailure medication rates, along with educational tools and targeted information, had a significant increase in the frequency.
Heartfailure is a leading cause of death worldwide and is especially fatal for people who don't have access to medical facilities. So, a team of researchers aims to bring heartfailure screening from the lab to the home.
FDA granted CardiAMP Cell Therapy a Breakthrough Device Designation for the treatment of ischemic heartfailure. Leslie Miller, MD , trial investigator at the CHF Heart Function Clinic at BayCare Morton Plant Hospital in Clearwater, Florida and a member of the CardiAMP HeartFailure II Study Executive Steering Committee. “As
Scientists discovered that blocking the activity of the hormone glucagon could treat a common and challenging type of heartfailure that affects millions worldwide.
The EMBARK-HFpEF multicenter, open-label trial examines the effects of cardiac myosin inhibition with mavacamten in patients with heartfailure with preserved ejection fraction with a left ventricular ejection fraction of 60% or greater.
mtaschetta-millane Wed, 07/31/2024 - 06:00 July 31, 2024 — A novel study co-authored by a heartfailure cardiologist at University Hospitals Harrington Heart & Vascular Institute, demonstrates the effectiveness of a newly developed scoring system in identifying patients with HeartFailure with Preserved Ejection Fraction (HFpEF).
Finerenone reduced the composite of total first and recurrent heartfailure (HF) events (hospitalizations for HF or urgent HF visits) and cardiovascular death in patients with HF and mildly reduced or preserved ejection fraction, according to an international clinical trial.
A novel study co-authored by a heartfailure cardiologist at University Hospitals Harrington Heart & Vascular Institute demonstrates the effectiveness of a newly developed scoring system in identifying patients with HeartFailure with Preserved Ejection Fraction (HFpEF).
Researchers have reduced scar formation and improved heart function in mouse models of heartfailure using a monoclonal antibody treatment, similar to that approved by the FDA to treat other conditions.
called SUMMIT, participants with heartfailure with preserved ejection fraction (HFpEF) and obesity taking tirzepatide for an average of 2 years had. Research Highlights: In an international trial of 713 adults in nine countries including the U.S.
Inhibiting the function of this protein, which is linked to congestive heartfailure (CHF), could potentially lead to a therapeutic effect on the heart.1,2 Inhibiting the function of this protein, which is linked to congestive heartfailure (CHF), could potentially lead to a therapeutic effect on the heart.1,2
Weight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heartfailure for patients with obesity and heartfailure with preserved pump function, new research reveals.
milla1cf Tue, 05/28/2024 - 07:00 May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with heartfailure, according to research presented at HeartFailure 2024 , a scientific congress of the European Society of Cardiology (ESC).
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content